Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.68 INR | -0.12% | -4.39% | +8.91% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+8.91% | 304M | |
-10.83% | 26.36B | |
+1.43% | 25.9B | |
+24.97% | 25.67B | |
+12.29% | 24.19B | |
+35.85% | 21.26B | |
+7.12% | 20.63B | |
-3.28% | 18.43B | |
+3.23% | 16.74B | |
+34.62% | 16.42B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook